Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
SARS-CoV2 Infections in Heart Transplant Recipients: Vaccines Still Are Our Greatest Weapon.
Anno:
2024
Long-term clinical follow-ups are needed to assess the effectiveness of vaccine and booster doses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection for heart transplant (HT) recipients, particularly in an epidemiological landscape characterized by rapidly changing viral variants. Among patients who received HT at Niguarda Hospital from January…
“A BROKEN TRANSPLANTED HEART”: A CASE OF TAKOTSUBO SYNDROME IN A HEART TRANSPLANT RECIPIENT
Anno:
2024
75-year-old female patient went to the emergency department for oppressive chest pain radiating to the left arm and dyspnea, developed after an argument with family members. The patient underwent heart transplant in 2010 because of chronic ischemic heart disease. In history: systemic arterial hypertension, former smoking, dyslipidemia, and chronic…
Navigating the Uncharted Waters: Managing Concurrent Cytomegalovirus Myocarditis and Allograft Rejection in a patient with Heart Transplantation
Anno:
2024
A 49-year-old female with hypertrophic cardiomyopathy underwent orthotopic heart transplantation. She was cytomegalovirus(CMV)-positive and received a heart from a CMV-negative donor, so prophylaptic therapy was not administered. Initial immunosuppression included cyclosporine and induction with Basiliximab in a steroid-free regimen. The first routine biopsy (EMB) showed mild focal cellular rejection…
Donors with Out of Hospital Cardiac Arrest (OHCA): a single-center experience
Anno:
2024
Aim – Out of Hospital Cardiac Arrest (OHCA) could be an alternative to existing efforts towards increasing the available pool of organs. The objective of this work is to demonstrate how hearts derived from marginal donors with Out of Hospital Cardiac Arrest (OHCA) have a quality that is not…